Patients should be aware that: No licensed combination product exists in the UK Any combination use would be considered experimental and is not supported by current evidence Clinical decisions must be guided by a qualified healthcare professional with access to current trial data Clinical Evidence and Trial Data Available to UK Patients Retatrutide Phase 2 data showed approximately 24% mean body weight reduction at the highest dose over 48 weeks, but no published trial data exist for the specific cagrilintideretatrutide combination
260.00 In stock Peptide science is expanding rapidly across many domains of biology
Ingredients: Deionized Water (Aqua),Glycerin,Sodium Hyaluronate (Hyaluronic Acid), Hydrolyzed Marine Collagen,Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7 (Matrixyl 3000), Acetyl Hexapeptide-8 (Argireline), DL-Panthenol (Vitamin B5), Beta Glucan,Copper Tripeptide-1(GHK-Cu),sh-Oligopeptide-1(EGF),Tetrasodium EDTA,Cichorium Intybus Extract(Chicory Root Extract),Phenoxyethanol-Ethylhexylglycerin(Euxyl PE 9010),PolyglutamicAcid
PMID: 16423593